Search for: "Patent Docs"
Results 681 - 700
of 1,321
Sorted by Relevance
|
Sort by Date
2 Mar 2009, 2:30 am
Dudas, Patent Rules Changes, and Patent Reform - a panel discussion on the Tafas case and patent reform bills recently considered by Congress featuring Chris Singer of McDonnell Boehnen Hulbert & Berghoff, and Patent Docs author, will discuss the Tafas v. [read post]
12 Apr 2024, 12:42 pm
Reg. 21242 (Mar. 27, 2024). [2] WIPO Industrial Design Law and Practice – Draft Articles, art. 3(1)(a)(ix), WIPO Doc. [read post]
13 Jan 2010, 3:00 am
Cobrek Pharmaceuticals, Inc (Patent Docs) Nexium (Esomeprazole) – US: Teva drops patent challenge following settlement agreement with AstraZeneca over Nexium (IP Factor) (GenericsWeb) Nuvigil (Armodafinil) - US: Mylan confirms first-to-file patent challenge relating to sleep-disorder drug (SmartBrief) Nuvigil (Armodafinil) - US: Cephalon sues Watson for patent infringement following Para IV challenge (Patent Docs) (GenericsWeb)… [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs) Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO… [read post]
12 Oct 2011, 3:46 am
No (FDA Law Blog) US: Patent battle over modified meganucleases heats up: Cellectis v Precision Biosciences (Holman’s Biotech IP Blog) (Patent Docs) US: Landmark NORD report on orphan drugs authored by HP&M Director shows FDA flexibility in approval (FDA Law Blog) Products Embeda (Morphine sulfate, Naltrexone hydrochloride) – US: Pfizer, Alpharma, King Pharma. file patent infringement suit against Watson following Para IV certification… [read post]
29 Jul 2009, 6:45 am
Tafas v Doll (Patent Docs) US: For stem cells, it seems that conception is enough: University of Pittsburgh v Hedrick (Patent Docs) (Patents4Life) US: General Accountability Office report on Bayh-Dole: Leverage to promote commercialisation of federally-funded inventions (PatentBIOtech) US: AlphaVax seeks review of BPAI decision awarding priority of invention to Novartis in interference between patents related to Alphavirus (Patent Docs)… [read post]
27 Apr 2010, 10:58 pm
US: MPEG LA announces formation of gene patent pool (Patent Docs) US: In an amended complaint, plaintiff adds count of false marking where defendants allegedly marked products with plaintiff’s patent number: Tripharma LLC v. [read post]
17 Nov 2010, 1:48 am
McNeil (EPLAW) Zymar (Gatifloxacin) – US: Allergan fails to secure new trial in Zymar case: Senju et al v Apotex (Patent Docs) [read post]
10 Jun 2015, 5:17 am
(See Declaration of Stephen Lobbin, Doc. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic… [read post]
8 Dec 2010, 2:20 am
Bulgarian Patent Office (Kluwer Patent Blog) Canada: World AIDS Day brings calls for legislative caution, reform (IP Watch) EU: EMA publishes guidelines for biosimilar antibodies (Part I – Patent Docs), (Part II – Patent Docs) EU: AstraZeneca and Nycomed raid by EU antitrust officials (GenericsWeb) India: Supreme Court dismisses Bayer’ petition in patent linkage matter (Generic Pharmaceuticals and IP) (Spicy IP)… [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) Opana (Oxymorphone) – US: Endo settles with Impax and Sandoz in Opana patent suits (Patent Docs) Sanctura (Trospium) – US: Patent infringement complaint filed following a Paragraph IV certification: Allergan Inc. et al. v. [read post]
24 Aug 2023, 7:00 am
This focus on jobs and GDP has caught the attention of both the Department of Commerce (DoC) and the USPTO. [read post]
22 Feb 2012, 5:49 pm
§ 271(e)(2) for patent infringement – see Orange Book Blog and Patent Docs posts), and as we all patiently await a decision from the U.S. [read post]
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases… [read post]
10 Aug 2014, 7:28 pm
The original report was then substantially tamed-down (with the most damning elements removed) before it was provided to the DOC Office of the Inspector General. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO:… [read post]
19 Oct 2011, 3:30 am
34/10) (Patent Docs) (Patent Docs) (IPKat) (IP finance) (Innovationpartners) (IAM) EU: SPCs – Every day counts – bu how do we count them? [read post]
13 Mar 2009, 2:00 am
(Patent Baristas) US: Schering merger includes legal headaches for Merck, including IP suits (Law360) US: Lessig and Eisen article ‘Is John Conyers Shilling for Special Interests’ concerning proposal to ban open access publishing requirement for taxpayer funded medical scientists (Huffington Post) (Lessig) (Lenz Blog) (Lessig) (Lenz Blog) (Michigan Messenger) (Lessig) US: McCain touts drug imports to lower US costs (Law360) US: Biotech and pharma provide little support… [read post]
14 Sep 2011, 12:10 am
Biogen – Additional views from Chief Judge Rader (Patent Docs) US: Classen v. [read post]
